- Home
- KNSA vs HTO Comparison
KNSA vs HTO Comparison
Compare KNSA & HTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- HTO
- Stock Information
- Founded
- KNSA 2015
- HTO 1985
- Country
- KNSA United Kingdom
- HTO United States
- Employees
- KNSA N/A
- HTO N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- HTO Water Supply
- Sector
- KNSA Health Care
- HTO Utilities
- Exchange
- KNSA Nasdaq
- HTO Nasdaq
- Market Cap
- KNSA 1.9B
- HTO 1.8B
- IPO Year
- KNSA 2018
- HTO N/A
- Fundamental
- Price
- KNSA $28.44
- HTO $52.28
- Analyst Decision
- KNSA Strong Buy
- HTO
- Analyst Count
- KNSA 5
- HTO 0
- Target Price
- KNSA $38.80
- HTO N/A
- AVG Volume (30 Days)
- KNSA 707.0K
- HTO 228.9K
- Earning Date
- KNSA 07-22-2025
- HTO 07-23-2025
- Dividend Yield
- KNSA N/A
- HTO 0.80%
- EPS Growth
- KNSA N/A
- HTO 12.16
- EPS
- KNSA N/A
- HTO 2.98
- Revenue
- KNSA $481,166,000.00
- HTO $766,656,000.00
- Revenue This Year
- KNSA $37.21
- HTO $6.61
- Revenue Next Year
- KNSA $5.32
- HTO $5.24
- P/E Ratio
- KNSA N/A
- HTO $17.69
- Revenue Growth
- KNSA 59.45
- HTO 12.34
- 52 Week Low
- KNSA $17.38
- HTO $44.91
- 52 Week High
- KNSA $30.69
- HTO $62.18
- Technical
- Relative Strength Index (RSI)
- KNSA 55.24
- HTO N/A
- Support Level
- KNSA $27.62
- HTO N/A
- Resistance Level
- KNSA $28.69
- HTO N/A
- Average True Range (ATR)
- KNSA 1.13
- HTO 0.00
- MACD
- KNSA -0.28
- HTO 0.00
- Stochastic Oscillator
- KNSA 45.78
- HTO 0.00
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.